AUTHORS
Jacob Wilkes, BS, LaDee Dangerfield, MS2, Gabriela Motyckova, MDPhD3, Carter Larsen4, Jesse Gygi, MHA, MPH5, Bradley Hunter, MD, MPH6
AFFILIATIONS
1 Intermountain Health, Salt Lake City, Utah, United States
2 Intermountain Health, Salt Lake City, Utah, United States
3 Intermountain Health, Salt Lake City, Utah, United States
4 Brigham Young University, Provo, Utah, United States
5 Intermountain Health, Salt Lake City, Utah, United States
6 Intermountain Health, Salt Lake City, Utah, United States
ABSTRACT
Introduction
Intermountain Health (IH) serves patients across more than five states in the Intermountain West, but an allogeneic stem cell transplant and its preparations typically require admission at IH LDS hospital in Salt Lake City, Utah. Patients and related donors are frequently required to travel large distances for needed treatment. Healthy donors collected by IH traditionally have received 4 days of granulocyte colony-stimulating factor (G-CSF; filgrastim) mobilization prior to peripheral blood stem cell collection. As part of quality improvement work investigating donors that had required multiple days of collection, in July 2025, it was determined that providing 5 days of G-CSF injections for stem cell mobilization prior to collection would likely improve collection efficiency and reduce the need for multiday donor collections.
Methods
The primary objective was to evaluate whether implementing 5-day G-CSF mobilization as the standard reduced the proportion of donors requiring more than one collection day. We identified allogeneic stem cell transplants performed at LDS hospital between January 2019 and April 2026 with donors age 18 years or older. Chart reviews were performed to capture information from both donor and recipient stored in the EMR, including the transplant roadmap. NMDP and American Red Cross documentation was also reviewed. The ratio of donor to recipient body weight was calculated and patients grouped into quartiles. Number needed to treat (NNT) was calculated based on the absolute rate reduction between the 5 and 4 day G-CSF groups. One tailed t-tests were used to compare means; Two-proportion z-tests were used to compare proportions. This study was determined to be exempt by the IH IRB.
Results
We identified 307 allogeneic stem cell transplants for 294 unique patients, 203 (66%) were IH-collected with 104 (34%) from a donor registry (NMDP or DKMS). LDS hospital performed an average of 36.1 allogeneic stem cell transplants per year.
Recipients overall were 54% male, 52.7 average age years, 4% Hispanic, 4% Non-white Race, 74% Married or Partnered, 7% Non-English speakers, 11% from outside Utah, 51% AML, 16% MDS, 11% ALL, 5% NHL, 4% CLL and 12% Other (Hodgkins, B-ALL, MPN, etc.), 12% Very High HCT-CI, 42% High or Very High DRI, 82% CMV positive, 49% Toxo IgG positive.
Donors overall were 55% male, average age 36 years, 55% CMV positive,
IH-collected donors were most often the recipients’ children (46%) and siblings (42%), with some instances of parents (5%) and other relations (5%). 5% Hispanic, 2% Non-white race, 4% Non-English speakers .
Recipients traveled an average of 82.8 miles one way to LDS hospital with 25% traveling 100+ miles; 11% from outside Utah. Donor travel burden was substantial, with IH-collected donors traveling an average of 200 miles with 29% traveling more than 100 miles; 18% coming from outside of Utah.
Among registry-collected donors, the mean collection volume was 7.0 (SD 3.1). IH-collected donors receiving 4 days of G-CSF mobilization had a mean collection volume of 7.3 (SD 3.1), compared with 7.2 (SD 3.3) among donors receiving 5 days of G-CSF. No significant difference in collection volume was observed between the 4-day and 5-day G-CSF groups (p=0.95).
Implementation of 5-day mobilization reduced multiday collections overall by 23 percentage points from 37% to 14% (67/181 to 3/22; p=0.15). This compares with a registry-collected donor rate of 5% (5/104). Multiday collections decreased from 78% to 0% (25/32 to 0/3; p=0.002) in the group with a donor-recipient weight ratio of 0.40-0.80, the lowest quartile. With an absolute risk reduction from 37% to 14%, the NNT was 4.3 donors. Approximately one multiday collection was avoided for every 4-5 donors receiving 5-day G-CSF mobilization.
Conclusion
A 5-day G-CSF mobilization protocol was associated with a significant reduction in multiday collection requirements among allogeneic PBSC donors. This strategy may improve donor experience, decrease the travel burden associated with nights away from home, and reduce collection-related resource utilization.
DISCLOSURES
Gabriela Motyckova, MDPhD: No relevant conflicts of interest to declare.